Skip to content

Single-Cell Discovery Grant in Oncology and Immunology

Single-Cell Discovery Grant in Oncology and Immunology

Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunology

Open single-cell discovery grant for oncology and immunology up to 100K Euro aimed at addressing unmet clinical needs.

Immunological diseases and Cancer are complex disorders and pose an enormous clinical burden due to diagnosis, stratification, and treatment challenges. Single-cell technologies are powerful in analysing the cellular landscape within complex diseases and are increasingly popular as a tool in identifying rare cells underlying the etiology of disease onset and progression in these areas. We are opening a single-cell discovery grant for oncology and immunology.

Scailyte is a recognized leader in combining single-cell analysis with artificial intelligence (AI) based data analytics. Our best-in-class algorithm associates patterns in single-cell data with disease status and further integrates multiple clinical parameters for a sensitive and impactful discovery.

We offer a co-finance partnership sharing 50% of costs (up to 100K Euro) for single-cell data acquisition including scRNA sequencing and CyTOF analysis, and subsequent artificial intelligence (AI)-based high-end bioinformatics services for translational oncology and immunology projects. The expected outcome of these grants should be addressing unmet medical needs and targets the discovery of clinically relevant biosignatures from single-cell data for diagnostic and prognostic pharmaceutical use. A maximum of three projects will be selected for this award through a formal selection process and notified within one month of the deadline.

Application:

Link to the brief application form: Click Here 

Deadline: 30th September 2021

Recent News

Machine learning meets multi-omics for precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics pow

Read more

Recent News

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better

Read more

Recent News

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

True precision medicine through single-cell science - Nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m

Read more

Recent News

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single

Read more

Recent News

WEBINAR: Supervised learning of disease-associated cell states and dynamics

Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit

Read more

Recent News

PODCAST: Discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams

Read more

Recent News

01 /04

Machine learning meets multi-omics for precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics pow

Read more

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better

Read more

Recent News

02 /04

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

03 /04

True precision medicine through single-cell science - Nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m

Read more

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single

Read more

Recent News

04 /04

WEBINAR: Supervised learning of disease-associated cell states and dynamics

Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit

Read more

PODCAST: Discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams

Read more

Recent News